{"Title": "Addition of docetaxel to hormonal therapy in low- And high-burden metastatic hormone sensitive prostate cancer: Long-term survival results from the STAMPEDE trial", "Year": 2019, "Source": "Ann. Oncol.", "Volume": "30", "Issue": 12, "Art.No": null, "PageStart": 1992, "PageEnd": 2003, "CitedBy": 51, "DOI": "10.1093/annonc/mdz396", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074637334&origin=inward", "Abstract": "\u00a9 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology.Background: STAMPEDE has previously reported that the use of upfront docetaxel improved overall survival (OS) for metastatic hormone na\u00efve prostate cancer patients starting long-term androgen deprivation therapy. We report on long-term outcomes stratified by metastatic burden for M1 patients. Methods: We randomly allocated patients in 2: 1 ratio to standard-of-care (SOC; control group) or SOC + docetaxel. Metastatic disease burden was categorised using retrospectively-collected baseline staging scans where available. Analysis used Cox regression models, adjusted for stratification factors, with emphasis on restricted mean survival time where hazards were non-proportional. Results: Between 05 October 2005 and 31 March 2013, 1086 M1 patients were randomised to receive SOC (n = 724) or SOC + docetaxel (n = 362). Metastatic burden was assessable for 830/1086 (76%) patients; 362 (44%) had low and 468 (56%) high metastatic burden. Median follow-up was 78.2 months. There were 494 deaths on SOC (41% more than the previous report). There was good evidence of benefit of docetaxel over SOC on OS (HR = 0.81, 95% CI 0.69-0.95, P = 0.009) with no evidence of heterogeneity of docetaxel effect between metastatic burden sub-groups (interaction P = 0.827). Analysis of other outcomes found evidence of benefit for docetaxel over SOC in failure-free survival (HR = 0.66, 95% CI 0.57-0.76, P < 0.001) and progression-free survival (HR = 0.69, 95% CI 0.59-0.81, P < 0.001) with no evidence of heterogeneity of docetaxel effect between metastatic burden sub-groups (interaction P > 0.5 in each case). There was no evidence that docetaxel resulted in late toxicity compared with SOC: after 1 year, G3-5 toxicity was reported for 28% SOC and 27% docetaxel (in patients still on follow-up at 1 year without prior progression). Conclusions: The clinically significant benefit in survival for upfront docetaxel persists at longer follow-up, with no evidence that benefit differed by metastatic burden. We advocate that upfront docetaxel is considered for metastatic hormone na\u00efve prostate cancer patients regardless of metastatic burden.", "AuthorKeywords": ["docetaxel", "hormone naive", "metastatic", "prostate cancer", "randomised control trial", "STAMPEDE trial"], "IndexKeywords": ["Aged", "Androgen Antagonists", "Antineoplastic Combined Chemotherapy Protocols", "Disease Progression", "Docetaxel", "Humans", "Male", "Middle Aged", "Neoplasm Metastasis", "Progression-Free Survival", "Proportional Hazards Models", "Prostatic Neoplasms", "Retrospective Studies"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85074637334", "SubjectAreas": [["Hematology", "MEDI", "2720"], ["Oncology", "MEDI", "2730"]], "AuthorData": {"7201772622": {"Name": "Clarke N.W.", "AuthorID": "7201772622", "AffiliationID": "60008873, 60028784", "AffiliationName": "Department of Urology, Christie and Salford Royal NHS Foundation Trusts"}, "57202679096": {"Name": "Hoyle A.", "AuthorID": "57202679096", "AffiliationID": "60008873, 60028784", "AffiliationName": "Department of Urology, Christie and Salford Royal NHS Foundation Trusts"}, "57213370273": {"Name": "Ali A.", "AuthorID": "57213370273", "AffiliationID": "60003771", "AffiliationName": "Genito-Urinary Cancer Research Group, Division of Cancer Sciences, University of Manchester"}, "57205510314": {"Name": "Ingleby F.C.", "AuthorID": "57205510314", "AffiliationID": "60031331", "AffiliationName": "London School of Hygiene and Tropical Medicine"}, "46660950100": {"Name": "Amos C.L.", "AuthorID": "46660950100", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "57195238765": {"Name": "Brawley C.D.", "AuthorID": "57195238765", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "57212803896": {"Name": "Calvert J.", "AuthorID": "57212803896", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "37030689700": {"Name": "Cook A.", "AuthorID": "37030689700", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "14014363300": {"Name": "Gilbert D.", "AuthorID": "14014363300", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "7201699564": {"Name": "Langley R.E.", "AuthorID": "7201699564", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "57212803966": {"Name": "MacNair A.", "AuthorID": "57212803966", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "56222126300": {"Name": "Millman R.", "AuthorID": "56222126300", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "7101982115": {"Name": "Ritchie A.W.S.", "AuthorID": "7101982115", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "57212801621": {"Name": "Rush H.", "AuthorID": "57212801621", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "55836382400": {"Name": "Sydes M.R.", "AuthorID": "55836382400", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "7102310808": {"Name": "Parmar M.K.B.", "AuthorID": "7102310808", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL"}, "9740870900": {"Name": "Attard G.", "AuthorID": "9740870900", "AffiliationID": "60109234", "AffiliationName": "UCL Cancer Institute"}, "8654568500": {"Name": "Chowdhury S.", "AuthorID": "8654568500", "AffiliationID": "60005518", "AffiliationName": "Guy's and Saint Thomas' NHS Foundation Trust"}, "25422700400": {"Name": "Rudman S.", "AuthorID": "25422700400", "AffiliationID": "60005518", "AffiliationName": "Guy's and Saint Thomas' NHS Foundation Trust"}, "7005462582": {"Name": "Cross W.", "AuthorID": "7005462582", "AffiliationID": "60020454", "AffiliationName": "St James University Hospital"}, "7004428943": {"Name": "Dearnaley D.P.", "AuthorID": "7004428943", "AffiliationID": "60010337", "AffiliationName": "Institute of Cancer Research"}, "57202591312": {"Name": "Parker C.C.", "AuthorID": "57202591312", "AffiliationID": "60017166", "AffiliationName": "Royal Marsden NHS Foundation Trust"}, "23481206800": {"Name": "Douis H.", "AuthorID": "23481206800", "AffiliationID": "60026493", "AffiliationName": "Department of Radiology, University Hospitals Birmingham, NHS Foundation Trust"}, "6701420776": {"Name": "Gillessen S.", "AuthorID": "6701420776", "AffiliationID": "60003771", "AffiliationName": "Division of Cancer Sciences, University of Manchester"}, "55547120726": {"Name": "Jones R.J.", "AuthorID": "55547120726", "AffiliationID": "60001490, 60000265", "AffiliationName": "Beatson West of Scotland Cancer Centre, University of Glasgow"}, "57191865079": {"Name": "Wallace J.", "AuthorID": "57191865079", "AffiliationID": "60001490, 60000265", "AffiliationName": "Beatson West of Scotland Cancer Centre, University of Glasgow"}, "16022194100": {"Name": "Malik Z.", "AuthorID": "16022194100", "AffiliationID": "60020939", "AffiliationName": "Clatterbridge Cancer Centre, NHS Foundation Trust"}, "24069354200": {"Name": "Tolan S.", "AuthorID": "24069354200", "AffiliationID": "60020939", "AffiliationName": "Clatterbridge Cancer Centre, NHS Foundation Trust"}, "7201987236": {"Name": "Mason M.D.", "AuthorID": "7201987236", "AffiliationID": "60023998", "AffiliationName": "Cardiff University"}, "56221680700": {"Name": "Matheson D.", "AuthorID": "56221680700", "AffiliationID": "60007173", "AffiliationName": "Faculty of Education Health and Wellbeing, University of Wolverhampton"}, "7404208954": {"Name": "Russell J.M.", "AuthorID": "7404208954", "AffiliationID": "60000265", "AffiliationName": "Institute of Cancer Sciences, Beatson West of Scotland Cancer Centre"}, "57212760309": {"Name": "Brown J.", "AuthorID": "57212760309", "AffiliationID": "60001881", "AffiliationName": "University of Sheffield"}, "24342787900": {"Name": "Beesley S.", "AuthorID": "24342787900", "AffiliationID": "100327411", "AffiliationName": "Kent Oncology Centre"}, "55932302300": {"Name": "Birtle A.", "AuthorID": "55932302300", "AffiliationID": "60022315", "AffiliationName": "Lancashire Teaching Hospitals, NHS Foundation Trust"}, "57194767531": {"Name": "Capaldi L.", "AuthorID": "57194767531", "AffiliationID": "60006687", "AffiliationName": "Worcestershire Acute Hospitals NHS Trust"}, "7101993489": {"Name": "Gale J.", "AuthorID": "7101993489", "AffiliationID": "60030999", "AffiliationName": "Portsmouth Oncology Centre, Queen Alexandra Hospital"}, "57014521800": {"Name": "Gibbs S.", "AuthorID": "57014521800", "AffiliationID": "60007937", "AffiliationName": "Queen's Hospital"}, "57205070128": {"Name": "Lydon A.", "AuthorID": "57205070128", "AffiliationID": "60176585", "AffiliationName": "Torbay and South Devon NHS Foundation Trust"}, "55565430100": {"Name": "Nikapota A.", "AuthorID": "55565430100", "AffiliationID": "122402721", "AffiliationName": "Sussex Cancer Centre"}, "22035377200": {"Name": "Omlin A.", "AuthorID": "22035377200", "AffiliationID": "60022646", "AffiliationName": "Department of Oncology and Haematology, Kantonsspital"}, "7201881233": {"Name": "O'Sullivan J.M.", "AuthorID": "7201881233", "AffiliationID": "60029738", "AffiliationName": "Centre for Cancer Research and Cell Biology, Queen's University Belfast"}, "24464040300": {"Name": "Parikh O.", "AuthorID": "24464040300", "AffiliationID": "60012878", "AffiliationName": "East Lancashire Hospitals NHS Trust"}, "8922675100": {"Name": "Protheroe A.", "AuthorID": "8922675100", "AffiliationID": "60170323", "AffiliationName": "Oxford University Hospitals, NHS Foundation Trust"}, "55122379100": {"Name": "Srihari N.N.", "AuthorID": "55122379100", "AffiliationID": "60004553", "AffiliationName": "Shrewsbury and Telford Hospital NHS Trust"}, "7101913763": {"Name": "Simms M.", "AuthorID": "7101913763", "AffiliationID": "60005954", "AffiliationName": "Hull and East Yorkshire Hospitals NHS Trust"}, "25628668500": {"Name": "Tanguay J.S.", "AuthorID": "25628668500", "AffiliationID": "60016901", "AffiliationName": "Velindre Cancer Centre"}, "57204865824": {"Name": "Wagstaff J.", "AuthorID": "57204865824", "AffiliationID": "60004572", "AffiliationName": "Swansea University, College of Medicine"}, "7005499470": {"Name": "Wylie J.", "AuthorID": "7005499470", "AffiliationID": "60028784", "AffiliationName": "Christie NHS Foundation Trust"}, "19838769200": {"Name": "Zarkar A.", "AuthorID": "19838769200", "AffiliationID": "60024356", "AffiliationName": "Heartlands Hospital"}, "7101943950": {"Name": "James N.D.", "AuthorID": "7101943950", "AffiliationID": "60019702", "AffiliationName": "Institute of Cancer and Genomic Sciences, University of Birmingham"}}}